SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-040288
Filing Date
2021-06-14
Accepted
2021-06-14 17:32:55
Documents
2
Period of Report
2021-06-10

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 1592
2 EX-24.1 DOCUMENT attachment1.htm EX-24.1 4057
  Complete submission text file 0001209191-21-040288.txt   6997
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CRISPR THERAPEUTICS AG 610 MAIN STREET CAMBRIDGE MA 02139
Business Address
Fleming Harold Edward (Reporting) CIK: 0001857250 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 211015679